Ketotrexate
- Level
- Commodity
- Parent
- 51111600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51111643This classification denotes a folate antagonist with the molecular formula C21H27N7O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 504RN634MM, chemically known as n-(p-((2-(2-amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)ethyl)amino)benzoyl)-l-glutamic acid but generally known as ketotrexate, which bears US NIH Compound Identifier 68691. European Medicines Agency schedules Ketotrexate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08378MIG. The term KETOTREXATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). KETOTREXATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ketotrexate under HS 29335995 and SITC 51576. As of Q4 2014, KETOTREXATE remains the US FDA Preferred Term for this commodity. Ketotrexate bears US NLM identifiers UMLS ID C2697842 and NCI Concept Code C77403. SMILES: O=C1NC([NH]C2NCC(N(C12)C)CCNC1CCC(CC1)C(=O)NC(CCC(=O)O)C(=O)O)N.
Same parent
Under 51111600 · 55Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.